Pharma & Biotech

Cisema will present critical China NMPA regulatory updates for medtech & pharma at RAPS Convergence 2026.

The presentation covered medical product registration in China, Greater Bay Area initiatives, and Hainan policy developments.

Cisema attended the Asia Summit on Global Health 2026 in Hong Kong, where healthcare leaders discussed the future of healthcare across Asia.

Meet Cisema at RAPS Euro Convergence 2026 in Lisbon and learn about regulatory pathways for drug and combination product development across the EU, China, and the US.

Join Stefanie Fasshauer’s session on China’s pharmaceutical regulatory system at PharmaSynergy-RX 2026

Cisema joined the Asia Summit on Global Health in Hong Kong to discuss healthcare innovation, investment, and new regulatory pathways connecting Hong Kong and China’s Greater Bay Area.